Consequently, postoperative detection of CTCs would be a supplementary diagnostic tool to conventional serial check of serum CEA in the ‘early’ recognition of early relapse in stages II–III colon cancer patients receiving curative surgery. This evidence concerns the gene CEACAM5 and colonic neoplasm.